ASAyla Eker Sariboyaci

Ayla Eker Sariboyaci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayla Eker Sariboyaci has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of a High‐Sensitivity Electrochemical Biosensor for Domoic Acid and Its Cellular Impact on Human Stem and Neuron‐Like Cells

    by Emilia Qomi Ekenel, Yucel Koc, Burcugul Altug, Merve Nur Soykan, Bahar Demir Cevizlidere, Sibel Gunes Bagis, Onur Uysal, Tugba Semerci Sevimli, Murat Sevimli, Ayla Eker Sariboyaci, et al.

    Domoic acid (DA) is an important environmental neurotoxin produced by certain types of marine algae and can accumulate in seafood such as anchovies, sardines, and mussels, which are considered healthy and widely consumed globally. One of the most important issues to consider is taking necessary measures to prevent water and marine pollution and conducting proper safety controls before consuming seafood. This study aimed to develop a high‐sensitivity electrochemical biosensor system for detecting DA in seafood, aiding marine pollution monitoring. Additionally, the cytotoxicity of DA at the highest Food & Drug Administration (FDA)‐permitted concentration and the concentrations determined in this study was examined on human cells. Gene expression related to cytotoxic response, DNA repair, and neurotoxicity was analyzed using amniotic fluid‐derived mesenchymal stem cells (hAF‐MSCs) and the human neuroblastoma cell line (SH‐SY5Y) as neuron‐like cell models. DA did not significantly affect the viability of hAF‐MSCs or SH‐SY5Y cells at 48‐h exposure but slightly reduced viability at 100 μg/mL compared to the control group. DA activated the glutamate receptor in hAF‐MSCs but not in SH‐SY5Y cells. It also reduced DNA repair capacity in hAF‐MSCs, though effects on viability and proliferation likely did not manifest within 48 h. There was no change in gene expression at 75 ng/mL of DA, which indicated the tolerable daily intake set by the FDA. The SH‐SY5Y cells exhibited resistance against DA, indicating enhanced their DNA repair to prevent themselves against apoptosis and cell death. It is also supported by the upregulation of DNA repair‐related genes and the membrane transporter gene ABCG2.

  • Open Access

    Effects of r-Klotho on MMP/TIMP Balance and TNF-α in Colon Cancer and Normal Colon Epithelial Cells

    by Onur Uysal, Tayfun Şengel, Lamiya Mahmudova, Merve Nur Soykan, Ayla Eker Sarıboyacı, Sibel Güneş Bağış

    Objective: To evaluate the effects of recombinant klotho protein (r-klotho) on human colon adenocarcinoma cells (Caco-2) and normal colon epithelial cells (CCD 841 CoN), with a focus on extracellular matrix (ECM) remodeling and inflammation-related gene expression. Materials and Methods: Caco-2 and CCD 841 CoN cells were cultured in four experimental groups: CCD 841 CoN; Caco-2; r-klotho-treated CCD 841 CoN; and r-klotho-treated Caco-2. r-klotho was administered at 0.3 μg/mL, selected from a previous dose–response study as the concentration yielding the lowest relative viability in Caco-2 cells within the tested range, for 24 and 48 hours. Expression levels of MMP-1, MMP-3, MMP-13, TIMP-1, TIMP-3, and TNF-α were analysed using quantitative real-time PCR (qRT-PCR) and evaluated by the ΔΔCt method with GAPDH as the reference gene. Results: In Caco-2 cells, r-klotho significantly reduced MMP-1 and TIMP-1 expression (p

  • The Effect of Wharton s Jelly Mesenchymal Stem Cell Application on Haematological Parameters in Cows with Subclinical Mastitis

    by Ayşegül BULUT, Merve Nur Soykan, Fatih Aladağ, Ayla Eker Sariboyaci, Durmuş HATİPOĞLU, Onur Uysal, Sibel Güneş Bağiş, Süleyman Gökhan Kara, Bahar Demi̇r Cevi̇zLi̇dEre, Burcugül Altuğ, et al.

    This study aimed to investigate the effect of intramammary Wharton's Jelly mesenchymal stem cell (WJ-MSC) administration on haematological parameters in cows with subclinical mastitis. In the study, 20 Holstein cows kept under equal care and feeding conditions during the same lactation period were used. The California Mastitis Test (CMT) was applied to identify animals with subclinical mastitis. Animals were divided into 4 groups: control (n=4, 3 ml DMEM solution, intramammary, days 2 and 9), Wharton's Jelly mesenchymal stem cells (n=4, WJ-MSCs, 2.5 x 107 WJ-MSCs, intramammary, days 2 and 9), subclinical mastitis (n=6, SM, parenteral antibiotic treatment, days 2 and 9), and SM+WJ-MSCs (n=6, 2.5 x 107 WJ-MSCs, days 2 and 9). On the 1st and 30th days of the study, blood samples were taken directly from the jugular vein under aseptic conditions into EDTA tubes containing anticoagulant for the evaluation of haematological parameters. Parameters related to infection and inflammation were evaluated in blood count analyses. It was found that the reference ranges for the parameters leukocyte (WBC), erythrocyte (RBC), haemoglobin (HGB), haematocrit (HCT), platelet (PLT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), neutrophil percentage Neu (%), and lymphocyte percentage (Lym%) varied. The WBC value, which was above the reference range on day 1, was measured within the reference range on day 30. It was found that the Neu% value, which was above the reference value in the Day 1 measurement, and the Lym% value, which was below the reference value, were within the reference values in the post-treatment measurement. The results obtained indicate that the application of WJ-MSCs has no negative effect on haematological parameters and may even play a balancing role in the inflammatory response for some parameters due to its immunomodulatory effects.

  • Therapeutic potential of human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) for treating clinical and subclinical mastitis in dairy cows

    by Durmus Hatipoglu, Mehmet Burak Ates, Ayla Eker Sariboyaci, Onur Uysal, Merve Nur Soykan, Burcugul Altug, Bahar Demir Cevizlidere, Fulya Buge Ergen, Aynaz Ghorbani, Fatih Aladag

  • Effective separation of DNA from bacterial cell walls using nanofibers in a lab on a chip system

    by Shadab Dabagh, Roshan Javanifar, Murat Kaya, Aliakbar Ebrahimi, Sultan Butun Sengel, Tugba Semerci Sevimli, Cihan Darcan, Fatma Dogan Guzel, Ayla Eker Sarıboyacı, Onur Uysal, et al.


  • Selenium in the treatment of colon cancer: Investigation of effect on epithelial mesenchymal transition

    by Sibel Güneş Bağış, Özlem Tomsuk, Fulya Büge Ergen, Ayla Eker Sarıboyacı, Onur Uysal

    Aim: This study aimed to investigate the therapeutic effect of seleno-L-methionine (SLM), a selenium (Se) compound, on colorectal cancer (CRC) cells through epithelial-mesenchymal transition (EMT)-related transcription factors (ZEB1 and ZEB2). Materials and Methods: The human colon carcinoma cell line (Caco-2) was treated with different concentrations of SLM (15.6–250 nmol/L) for 24 hours. Cell viability was assessed using the MTT assay, live/dead rate and morphology were evaluated by Calcein-AM/Propidium Iodide staining, and ZEB1 and ZEB2 gene expressions were analyzed by qRT-PCR. Results: SLM decreased cell viability in a dose-dependent manner (IC50: 31.25 nmol/L). Live/dead analysis revealed a significant increase in non-viable cells in the SLM-treated group compared to controls, although clear apoptotic morphology was not consistently observed. qRT-PCR analysis revealed a significant downregulation of ZEB2 and a slight reduction in ZEB1 expression. Conclusion: SLM exhibited cytotoxic effects and modulated EMT-related gene expression, suggesting potential therapeutic implications in CRC.

  • Open Access

    Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes

    by Onur Uysal, Haya Erybeh, Mediha Canbek, Emilia Qomi Ekenel, Sibel Gunes, Gülay Büyükköroğlu, Tugba Semerci Sevimli, Fatih Cemrek, Ayla Eker Sariboyaci

    Background: Cartilage injuries are currently the most prevalent joint disease. Previous studies have emphasized the use of stem cells as the effective treatment for regenerating cartilage damage. Objective: In this study, considering the difficulties of the cellular therapy method, it was hypothesized that human synovial fluid-derived mesenchymal stem cell (hSFMSC) exosomes as a SC source could be used to treat these injuries as a safer and cell-free therapeutic alternative procedure due to its direct relevance to cartilage regeneration. Moreover, this study aimed to determine the miRNA and target genes required for the formation of SC treatment combined with gene therapy in order to reveal the mechanism of cartilage regeneration and increase its effectiveness. Methods: MSCs were characterized by flow cytometry, and immunocytochemical and differentiation analyses were done. To characterize functionally isolated exosomes, in vitro uptake analysis was performed. RT-qPCR was used to examine in terms of the advantages of cellular and cell-free therapy, mature human chondroblasts derived by differentiation from hSF-MSCs and human chondrocyte profiles were compared in order to demonstrate the above profile of hSF-MSCs and exosomes isolated from them, and the effectiveness of SC therapy in repairing cartilage damage. Results: According to our findings, the expression level of hsa-miR-155-5p was found to be considerably higher in chondrocytes differentiated from human synovial fluid MSCs than in mature human chondrocytes. These findings were also supported by the TGF-signalling pathway and chondrogenesis marker genes. Conclusion: It was concluded that hSF-MSCs and exosomes can be used in the treatment of cartilage damage, and hsa-miR-155-5p can be used as a target miRNA in a new gene therapy approach because it increases the therapeutic effect on cartilage damage.


  • Open Access

    Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells

    by Bahar Demir Cevizlidere, Onur Uysal, Huseyin Avci, Sibel Gunes Bagis, Tugba Semerci Sevimli, Murat Dincer, Emilia Qomi Ekenel, Suleyman Gokhan Kara, Merve Nur Soykan, Ayla Eker Sariboyaci

    Due to their high expression profile of multi‐drug resistance genes, cancer stem cells (CSCs) are the main source of drug resistance. The aim of this study was to establish a gemcitabine‐hydrochloride‐resistant (rt) human non‐small cell lung cancer (hNSCLC) cell line and their CSC line to be used as disease models in various cancer studies. In the first phase of study, a gemcitabine hydrochloride‐rt hNSCLC line cells was produced by making them rt through periodic exposure to gemcitabine hydrochloride. This acquired gemcitabine‐hydrochloride‐rt hNSCLC cell line was characterized for resistance. Subsequently, a CSC population with a CD326 + CD133 + CD44+ phenotypes was immunoselectively isolated from gemcitabine hydrochloride‐rt hNSCLCs purified from a single cell by colony forming technology. This rt CSC line was characterized for both resistance and stemness. Rt and non‐rt CSCs were analyzed and compared with each other in terms of immunophenotyping the expression profiles of ALDH1, CD90, ABCG2, CD44 and MDR1, which are CSC specific markers, of demonstrating mitotic capacity with growth curve analysis and of their ability to form tumor spheroids in three different 3D cultures. The results of this study demonstrated for the first time the successful generation of both gemcitabine‐hydrochloride‐rt hNSCLC cells and CSCs derived from gemcitabine‐hydrochloride‐rt hNSCLC cells. It was also shown that isolated and characterized rt CSCs could proliferate and form tumor spheres in vitro using three different 3D in vitro techniques. It was shown that the cell surface markers CD326, CD133 and CD44 can serve as an antibody panel for CSCs.


  • Open Access

    Crosstalk among miR ‐29, α‐SMA , and TGFβ1 /β3 in melatonin‐induced exosome ( Mel‐prExo ) treated human limbal mesenchymal stem cells ( hLMSCs ): An insight into scarless healing of the cornea

    by Burcugul Altug, Merve Nur Soykan, Sevinc Eyubova, Ayla Eker Sariboyaci, Cezmi Dogan, Onur Ozalp, Eray Atalay

    Inflammatory mediators that infiltrate the corneal stroma after corneal infections, trauma or refractive surgery can trigger the transformation of corneal keratocytes into myofibroblasts, resulting in highly irregular collagen deposition and subsequently corneal scarring. Mesenchymal stem cells (MSCs) can be used as therapeutic agents to regenerate corneal and conjunctival tissue damage, regulate inflammation, and reduce the development of limbal stem cell failure. The use of MSC‐derived exosomes as a cell‐free therapeutic vector is a novel therapeutic approach. This study aimed to assess the effect of exosomes obtained from melatonin (Mel)‐treated human limbal mesenchymal stem cells (hLMSCs) on naïve hLMSCs and to determine their influence on the antifibrotic and pro‐regenerative pathways involved in corneal scarring. hLMSCs were treated with varying concentrations of Mel, followed by isolation and characterization of the procured exosomes (Mel‐prExos). These exosomes were added to the cell culture media of naïve hLMSCs to examine their antifibrotic and pro‐regenerative effects. The expression of miR‐155, miR‐29, TGFβ1, TGFβ3, PPARγ, and α‐SMA miRNAs and genes were compared between Mel‐treated hLMSCs and Mel‐prExo‐treated hLMSCs by using real‐time PCR. We found that at 1 μM Mel and in the presence of Mel‐prExos, TGFβ1 was expressed 0.001‐fold, while TGFβ3 was expressed 0.6‐fold. miR‐29 expression was increased 38‐fold in the control‐Exo group compared to that in the control group. Changes in TGFβ1/β3 and α‐SMA expression are associated with miR‐29 and miR‐155. This approach could prove beneficial for ocular surface tissue engineering applications.


  • Open Access

    Evaluation of the Effect of Breast Milk Storage Conditions on the Viability of Cells in Breast Milk: A Pilot Study

    by Ozge Surmeli Onay, Merve Tutal, Burcugul Altug, Ozge Aydemir, Tugba Barsan Kaya, Ayla Eker Sarıboyacı, Ayse Neslihan Tekin